Researchers in China investigated the prevalence of bronchiectasis in different phenotypes of subjects with COPD and the correlation between bronchiectasis and different phenotypes, especially ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Bronchiectasis ...

Bronchiectasis hospitalizations have higher mortality and costs than COPD and asthma, with a median stay of 5 days and costs of $50,393. During the COVID-19 pandemic, bronchiectasis hospitalizations ...

Suspected bronchiectasis, defined as a combination of clinical symptoms and radiologic evidence of abnormal airways, is associated with a 15% higher risk for death in adults with normal spirometry, ...

Please provide your email address to receive an email when new articles are posted on . Researchers found significantly reduced odds for hypertension and diabetes among those with bronchiectasis vs.

Bronchiectasis is independently associated with an increased mortality risk in patients with moderate-to-severe COPD, according to a new study from researchers in Spain. Bronchiectasis, a permanent ...

Miami (November 11, 2025) – Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung disease report differences in symptoms, mental ...

CHAPEL HILL, N.C. & MIAMI--(BUSINESS WIRE)--Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for the treatment of ...

Researchers analyzed a US national database to compare outcomes of hospitalizations for bronchiectasis exacerbations with those for COPD and asthma exacerbations among adults hospitalized between 2017 ...

Please provide your email address to receive an email when new articles are posted on . Diagnosis-related anxiety, depression or fear was reported by a larger proportion of women vs. men. After being ...

CHAPEL HILL, N.C. & MIAMI--(BUSINESS WIRE)--Renovion and COPD Foundation Joint Release – Renovion, Inc. has announced that the first patient has been enrolled in a Phase 2 clinical study evaluating ...

Sep. 24—(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 adults nationwide, is necessary to slow disease progression and help ...